Medical condition
Myelodysplastic Syndrome
Myelodysplastic Syndrome is a medical condition tracked by NovaPharmaNews across 10 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- lenalidomide (LENALIDE) Antineoplastic and immunomodulating agents (L04)
- filgrastim (NIVESTIM) Antineoplastic and immunomodulating agents (L03)
- posaconazole (PHARMACOR POSACONAZOLE) Antiinfectives for systemic use (J02)
- lipegfilgrastim (LONQUEX) Antineoplastic and immunomodulating agents (L03)
- azacitidine (AZACITIDINE ACCORD) Antineoplastic and immunomodulating agents (L01)
- luspatercept (REBLOZYL) Blood and blood forming organs (B03)
- pegfilgrastim (PELGRAZ) Antineoplastic and immunomodulating agents (L03)
- efbemalenograstim alfa (RYZNEUTA) Antineoplastic and immunomodulating agents (L03)
- epoetin zeta (RETACRIT) Blood and blood forming organs (B03)
- imetelstat (RYTELO) Antineoplastic and immunomodulating agents (L01)